Navigation Links
Antibiotics, antimicrobials and antifungals in waterways
Date:6/9/2009

This release is available in French.

Montreal, June 9, 2009 Antibiotics, antimicrobials and antifungals are seeping into the waterways of North America, Europe and East Asia, according to an investigation published in the peer-reviewed journal Environmental Health Perspectives (EHP). Authored by Universit de Montral and Environment Canada researchers, the review found that consumption of anti-infectives for human and agriculture use contributes to their release into the environment and even into drinking water.

"Anti-infectives are constantly discharged, at trace levels, in natural waters near urban centres and agricultural areas," says senior author Sbastien Sauv, a Universit de Montral professor of environmental analytical chemistry. "Their potential contribution to the spread of anti-infective resistance in bacteria and other effects on aquatic biota is a cause for concern."

The research team compiled published data for three classes of antibiotics (macrolides, quinolones and sulfonamides) and the compound trimethoprim present in the urban wastewaters of East Asia, Europe and North America. The scientists found higher concentrations of these pharmaceuticals in raw wastewater compared to treated wastewater.

"Rivers, creeks, lakes, estuaries, basins, sea waters and wells have been reported to be contaminated by several of these compounds," says Dr. Sauv, adding that a previous review by the scientific team also demonstrated that pharmaceuticals could promote microbial resistance when released in the environment.

This latest review warns the increased farm usage of anti-infectives may augment their levels in future agricultural wastewater. The investigation also predicts that vital urban water conservation strategies could produce harmful side-effects -- specifically less wastewater resulting in lower dilution and higher concentrations of anti-infectives in wastewater.

"Anti-infectives might have a greater impact in developing countries, where sewage infrastructure can be lacking, over-the-counter drugs more widely available and industrial emissions less strict," adds first author Pedro A. Segura, a Universit de Montral PhD student.


'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Related medicine news :

1. Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?
2. Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
3. UIC researchers measure health effects of Chicagos waterways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Utah (PRWEB) , ... February 28, 2017 , ... ... held Overl.ai Inc., a healthcare automation intelligence company based in New York. , ... is ensuring the provider’s workflow remains unaltered. Those two fundamental reasons are the ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and overall body strength, which often leads to a host of health issues, ... of the American Geriatrics Society discovered that good overall muscle strength in ...
(Date:2/27/2017)... ... February 27, 2017 , ... The threat of nuclear ... work for a company involved in the underground testing of nuclear weapons. Years later, ... Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical decisions ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... Morristown, New Jersey (PRWEB) , ... February 27, 2017 , ... ... the highest cancer rates, among all types and genders. And the need for advanced ... led by RWJ and its top-rated cancer care program, in collaboration with their non-profit ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... 28, 2017 ... Research and Markets has announced the ... 2025" report to their offering. The global ... of USD 239.8 billion by 2025. The rising prevalence of lifestyle-induced ... over the forecast period. Advancements in recombinant molecular technologies and high ...
(Date:2/28/2017)... , Feb. 28, 2017  Rigel Pharmaceuticals, Inc. ... it will report its fourth quarter and year ... March 7, 2017.  Rigel senior management will follow ... webcast at 5:00pm Eastern Time (2:00pm Pacific Time) ... can access the live conference call by dialing ...
(Date:2/28/2017)... SOUTH SAN FRANCISCO, Calif. , Feb. 27, ... company developing proprietary therapeutics for the treatment of ... drug delivery platform, today announced that the U.S. ... initial review of the ropinirole implant Investigational New ... hold the initiation of the clinical study pending ...
Breaking Medicine Technology: